Konzept
Konzept offers drug development consulting services to early stage biotech companies and investment funds, focusing on drug development strategy, R&D operations, and due diligence projects. Led by Dr. Tilmann M. Brotz, the company leverages extensive industry experience to support clients in various therapeutic areas and development stages.
Industries
bioinformatics
biopharma
biotechnology
consulting
outsourcing-59ca
pharmaceutical
Nr. of Employees
small (1-50)
Konzept
Services
Consulting on drug development strategy, preclinical efficacy models, toxicology, DMPK, translational research and regulatory document drafting.
Implementation of virtual R&D operations, project and portfolio management, CRO/CMO selection and study oversight.
Technical and strategic due diligence for investment decisions, in-licensing and out-licensing opportunities.
Consulting on drug development strategy, preclinical efficacy models, toxicology, DMPK, translational research and regulatory document drafting.
Implementation of virtual R&D operations, project and portfolio management, CRO/CMO selection and study oversight.
Technical and strategic due diligence for investment decisions, in-licensing and out-licensing opportunities.
Expertise Areas
- Drug development strategy
- Preclinical development
- Clinical development planning
- Toxicology and safety assessment
Key Technologies
- Preclinical efficacy models
- Toxicology testing and safety assessment
- DMPK / ADME studies
- Biomarker validation